Neutra Corp (OTCMKTS:NTRR) is planning to support its vertical integration campaign with the fresh round of private equity. It will use the funds to become a vertically integrated producer and distributor of the hemp-derived CBD health products.
Private equity to support accomplishments in 2020
Chief Executive Officer of Neutra, Sydney Jim, said the private equity received on January 1, 2020, is a welcome sign for the company to strengthen its long term position and compete and achieve success. The company will use the funds to pursue its goals and strategies. It enjoyed successful 2019 and hopes to maintain better accomplishments in 2020 with the fresh round of private equity.
CBD offers a variety of medical benefits
The multi-purpose and natural hemp compound offers a variety of medical benefits. According to the feedback from users, it offers relief from reduced effects of seizures, anxiety, and slows down in neurodegenerative disorders. It also provides relief from pain and alleviates the side effects of certain cancer treatments. Users do not suffer from any form of addiction.
The market for hemp-derived products expects to touch $22 billion by the year 2022. It is on the backdrop of improved health benefits enjoyed by the users of CBD. The sales of CBD last year are $390 million.
Neutra gets a boost from TDA’s administrative rules
Neutra is almost closer to realize its dream of becoming a vertically integrated company because the administrative rules framed by the Texas administration regarding the production of hemp are public comments stage. On adoption of these rules, the Texas Administration (TDA) still needs to get the nod of USDA (the US Department of Agriculture) to issue licenses for growing hemp.
TDA expects to process the license applications in H1 2020. Neutra will grow its hemp on receipt of the license. The company will use the grown hemp for the production of CBD products and distribute them under one roof. Sydney said it is a big development. The demand for hemp-derived CBD products in Texas is huge. It is economical to produce hemp in the state. The company will also benefit from logistics. Combined gives Neutra a solid footprint in the southern US.
Companies Strengthening Leadership Position: Stock to Watch Aleafia Health Inc (OTCMKTS: ALEAF) and Item 9 Labs Corp (OTCMKTS: INLB)
Aleafia Health Inc (OTCMKTS: ALEAF) and Item 9 Labs Corp (OTCMKTS: INLB) were looking to hire the senior position to support the company’s growth plan. As a result, Aleafia Health Inc (OTCMKTS: ALEAF) announced the appointment of its Chairman. On the other hand, Item 9 Labs Corp (OTCMKTS: INLB) hired several candidates in its strategic management team to support its growth.
New Chairman to support sustainable growth
Aleafia Health Inc (OTCMKTS: ALEAF), leading players in cannabis wellness products globally, announced the appointment of Mark J. Sandler as Chairman. Sandler is the longest-serving member of Aleafia Health’s board and was head of its Governance Committee. He is a leading trial and appellate lawyer. Besides this, he is also an adjudicator and mediator in regulatory matters, including securities litigation. Further, Mr. Sandler has served three terms as an elected member of the Law Society of Ontario’s governing body.
The company is well placed to continue on its sustainable growth story. The company has marked its presence in the cannabis wellness product segment globally, from a start-up to a leading global company. In line with the company’s vision, the board under the leadership of Mr. Sandler will prioritize strong cooperative governance and sustainable growth in the medical and international markets.
Strengthening the strategic management team to support its growth
Item 9 Labs Corp (OTCMKTS: INLB) announced that the company hired several potential candidates to support its franchise expansion. The company is a vertically integrated cannabis dispensary franchisor. The company stated that they have successfully opened its first franchisee in Boulder, Colorado. To expand its franchisee, the company has hired Tracy Timko, as a Director of Franchise Support, Erica Tarnowski, as a Franchise Development Manager, Mike Keskey II as a General Counsel, Shabrina Glass as Executive Assistant. The company stated the new team is expected to add tremendous value to its growth and enable the company to scale its brands to their full potential. Besides this, the company is also looking for a potential candidate for several other senior-level positions to drive its vision.
Skye Bioscience Inc. (OTCMKTS: SKYE) Adds Praveen Tyle to the Board of Directors as Medical Marijuana, Inc.’s (OTCMKTS: MJNA) Subsidiary Kannaway Joins Influential Japanese Groups in the Hemp Industry
It seems the recent approvals of cannabinoid-based therapies are still not enough. According to Skye Bioscience Inc. (OTCMKTS: SKYE), they have just scratched the surface of the potential of how modulation of the ECS can impact health. So the biotech is quickly intervening. Thanks to its advanced technologies, which represent a scientific approach to realizing the pharmaceutical potential of cannabinoids. THCVHS is the company’s lead program and is focused on treating glaucoma an illness, which causes irreversible blindness.
In its endeavor to scale up its operations, Skye has added Praveen Tyle to its Board as an independent director. The current President and Chief Executive Officer of Invectys, Inc. boast over 35 years of experience in the pharmaceutical industry.
“…with expertise originating from a deep scientific foundation, Praveen has extensive cross-functional experience working with companies at various stages spanning big pharma through start-up biotech…,” CEO and Chair of Skye Bioscience, Punit Dhillon commented.
Given his academic insight in clinical development, manufacturing, regulatory, and business development, Dr. Tyle will have the noble task of taking Skye to the next level of success in ophthalmic innovations and drug delivery. Besides, he has a wealth of industry exposure in multiple disease areas, including ocular disorders.
Kannaway Joins Two of the Leading Hemp Industry Organizations in Japan
Admission into some of the influential groups within an industry comes with honor. Kannaway, a subsidiary of Medical Marijuana, Inc. (OTCMKTS: MJNA), understands exactly what this means. The network sales and marketing company is now part of the influential groups in the Hemp industry in Japan; Hokkaido Industrial Hemp Association (HIHA) and Association for Japan Cannabinoid (AJC).
The company became an ambassador of tetrahydrocannabinol (THC)-free cannabidiol (CBD) products for personal in 2019. And since then, it has encountered potential growth opportunities. Hence, it will become one of the beneficiaries of the Japanese CBD market, which is rapidly expanding and is positioned to reach $5.3 billion by 2025.
According to Kannaway® CEO Blake Schroeder, their mission is to expand the rights for all citizens in Japan, whereby they can have easy access to hemp and hemp-derived products.
Trulieve Cannabis Corp (OTCMKTS: TCNNF) Expands its Footprint into the Southeast Hub; Thanks to a Production License Approval in Georgia
The emergence of new products in the cannabis industry is a growing trend and is contributing immensely to the accessibility of cannabis. Additionally, the continued removal of legal and regulatory barriers is placing the industry in a position of expansive growth. These and other similar happenings will work in favor of the likes of Trulieve Cannabis Corp (OTCMKTS: TCNNF).
The “seed-to-sale” company in the U.S. is also the first and largest fully licensed medical cannabis company in Florida. It distributes its in-house products in the state as well as directly to patients via home delivery. Today, it is a leading and top-performing cannabis company and has extended its services to Georgia. The approval of a production license Trulieve has solidified its presence in the Southeastern hub in the U.S. In addition, the license will facilitate the establishment of indoor cultivation and manufacturing facility in Adel.
Identifying and Developing Attractive Market Opportunities
As one of the oldest multi-state operators, Trulieve has established a strong track record. Thanks to solid foundations. Its approach and entry into the Georgia market explain its commitment to build the broadest patient access to medical marijuana in the state.
“As the largest cannabis company…We strive to invest in underserved communities, source local materials and labor wherever possible, and be a good neighbor and partner everywhere we operate and this is what we intend to bring to the town of Adel and to Cook County…,” the company’s CEO, Kim Rivers reported.
Trulieve has established a partnership with Harvest Health & Recreation Inc. through a deal worth $2.1 billion in other news. Rivers confirms that this is the largest and most exciting acquisition within the industry and will help them propel forward with an unparalleled platform for future growth.
The two companies will bring together their capabilities to scale their businesses, innovation with an unparalleled platform for future growth. Additionally, the partnership allows Trulieve to access the Arizona market.